Icon

LINZESS (nda202811)- (72MCG,145MCG,290MCG)

LINACLOTIDE ABBVIE
72MCG,145MCG,290MCG
Yes No
2033-Aug-16 2017-Aug-30
None None
None No
LINZESS is a guanylate cyclase-C agonist indicated in adults for treatment of: • Irritable bowel syndrome with constipation. (IBS-C) • Chronic idiopathic constipation.
1 1 0
Total Other Developers 18
Drugs with Suitability No
72MCG ** ** Up - -
145MCG ** ** Up - -
290MCG ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.